Robert Lenk
Director/Board Member en PLUS THERAPEUTICS, INC. .
Fortuna: 52 935 $ al 31/03/2024
Perfil
Robert P.
Lenk is the founder of The Liposome Co., Inc. (1981) and Argus Pharmaceuticals, Inc. (1989).
He is currently an Independent Director at Plus Therapeutics, Inc. (since 2020), a Director at POP Biotechnologies, Inc., a Partner at Houston Partners, and the President of Lenk Pharmaceuticals, LLC (since 2016).
His former positions include President & Chief Executive Officer at Therapeutics 2000, Inc. (1995-2003), President-Luna Nanoworks Division at Luna Innovations, Inc. (2004-2010), Chief Scientific Officer at MediVector, Inc., and President at OncoVector, Inc. He received his undergraduate and doctorate degrees from Massachusetts Institute of Technology.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
PLUS THERAPEUTICS, INC.
0.69% | 08/05/2024 | 29 327 ( 0.69% ) | 52 935 $ | 31/03/2024 |
Cargos activos de Robert Lenk
Empresas | Cargo | Inicio |
---|---|---|
PLUS THERAPEUTICS, INC. | Director/Board Member | 01/03/2020 |
Houston Partners
Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Lenk Pharmaceuticals, LLC | President | 01/01/2016 |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology POP Biotechnologies, Inc. is a biotechnology company. The private company is based in Buffalo, NY. The company was founded in 2015 by Jonathan Lovell, Jonathan Smyth, Kevin Carter. | Director/Board Member | - |
Antiguos cargos conocidos de Robert Lenk.
Empresas | Cargo | Fin |
---|---|---|
MediVector, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
LUNA INNOVATIONS INCORPORATED | Corporate Officer/Principal | 15/04/2010 |
Therapeutics 2000, Inc. | Chief Executive Officer | 01/09/2003 |
Argus Pharmaceuticals, Inc. | Founder | - |
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Founder | - |
Formación de Robert Lenk.
Massachusetts Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
LUNA INNOVATIONS INCORPORATED | Electronic Technology |
PLUS THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 8 |
---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
Argus Pharmaceuticals, Inc. | Health Technology |
Houston Partners
Houston Partners Investment ManagersFinance Houston Partners identifies regional and national investment opportunities and develops into nationally and internationally recognized public companies. It invests in early-stage and expanding companies, and focuses on the environment, technology, and health sciences. The company was founded in 1986 and is headquartered in Houston, TX. | Finance |
MediVector, Inc. | |
OncoVector, Inc. | |
Therapeutics 2000, Inc. | |
Lenk Pharmaceuticals, LLC | |
POP Biotechnologies, Inc.
POP Biotechnologies, Inc. BiotechnologyHealth Technology POP Biotechnologies, Inc. is a biotechnology company. The private company is based in Buffalo, NY. The company was founded in 2015 by Jonathan Lovell, Jonathan Smyth, Kevin Carter. | Health Technology |
- Bolsa de valores
- Insiders
- Robert Lenk